Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Plugging Up the Blood-Brain Barrier
19 June 2003. The blood-brain barrier (BBB) is cropping up with increasing frequency in discussions of Alzheimer's disease therapy. It is an ever-present concern for researchers hoping to introduce therapies-whether drugs, a vaccine, or stem cells-to the brain via a noninvasive route (see ARF related news story). Moreover, there are indications that the BBB was compromised in the recent clinical Ab immunization trials (see ARF related news story). .

In the June 15 Nature Medicine, researchers led by Kyu-Won Kim of Seoul National University in Korea, reports that a putative tumor suppressor called src-suppressed C-kinase substrate (SSeCKS, produced by the gene known as Akap12) regulates the formation of the BBB during embryonic development, and may play a role in its maintenance. Kim's team of scientists from Korea and the United States found evidence that SSeCKS expression is regulated by oxygen tension in the fine capillaries that are laid down during angiogenesis. As hypoxic regions gradually disappear from the developing brain, the expression of SSeCKS by astrocytes is upregulated, in turn inhibiting the migration of endothelial cells that form capillaries.

In addition, the authors report, SSeCKS promotes the process whereby the capillaries, in concert with astrocytes, form the tight junctions between endothelial cells that characterize the impermeable BBB. SSeCKS appears to effect these changes by downregulating expression of vascular endothelial growth factor (VEGF) through AP-1 reduction, and by upregulating expression of angiopoietin-1 (Ang-1), an astrocyte-derived antipermeability factor.

Previous work has shown that SSeCKS expression is ubiquitous in the adult brain. "[W]e suggest that the constitutive expression of SSeCKS in the adult brain may provide a stabilizing signal for BBB integrity under physiological conditions. A detailed understanding of BBB formation by SSeCKS will be helpful in the development of therapeutics for brain diseases related to BBB disruption," write the authors. Perhaps this knowledge will also be useful for understanding how the BBB changes in diseases such as Alzheimer's, and what role, if any, angiogenesis plays in this process.-Hakon Heimer.

Reference:
Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ, Kim KW. SSeCKS regulates angiogenesis and tight junction formation in blood brain barrier. Nat Med. 2003 Jul;9(7):900-906. Abstract

 
Comments on News and Primary Papers
  Comment by:  Wallace Dembski
Submitted 23 July 2003  |  Permalink Posted 3 August 2003
  I recommend the Primary Papers
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad